Who is sponsoring NCT03580057?

NCT03580057 is sponsored by University of Oslo.

What drugs are being tested in NCT03580057?

Interventions in NCT03580057: Breastfeeding promotion intervention, Diet and weight loss intervention.

What condition does NCT03580057 study?

NCT03580057 studies Cardiovascular Risk Factor.

Is NCT03580057 still recruiting?

NCT03580057 is currently completed. Last updated 21 March 2024.

Last reviewed 2024-03-21 · How we verify

NCT03580057: EVA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Weight Loss and Lactation (the EVA-trial)

Completed NA Last updated 21 March 2024

What this trial tests

NA trial testing Breastfeeding promotion intervention in Cardiovascular Risk Factor in 156 participants. Completed in 15 December 2023.

Timeline

30 January 2018

Primary endpoint
15 December 2023

15 December 2023

Quick facts

Lead sponsor	University of Oslo
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	prevention
Enrollment	156
Start date	30 January 2018
Primary completion	15 December 2023
Estimated completion	15 December 2023
Sites	1 location across Norway

Drugs / interventions tested

Breastfeeding promotion intervention
Diet and weight loss intervention

Conditions studied

Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →

Sponsor

University of Oslo

Who can join

18 and older, female only, with Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized controlled trial aiming to investigate the effects and possible interactions of diet induced weight loss and lactation on cardiometabolic profile

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Relative validity of bioelectrical impedance analysis in estimating body composition in women with overweight and obesity 2 weeks and 6 months postpartum.
Westerheim E, Øhman EA, Fossli M, Winkvist A, et al · · 2025 · cited 2× · PMID 39974841 · DOI 10.29219/fnr.v69.10869
Effects of Breastfeeding Promotion Intervention and Dietary Treatment in Postpartum Women with Overweight and Obesity: Results from a Randomized Controlled Trial on Weight and Cardiometabolic Risk Factors.
Øhman EA, Fossli M, Rasmussen KM, Winkvist A, et al · · 2024 · cited 2× · PMID 38901636 · DOI 10.1016/j.tjnut.2024.06.006
Nutrient Intake Among Lactating Women With Overweight and Obesity in Norway: A Comparison With the Nordic Nutrition Recommendations 2023.
Fossli M, Øhman EA, Andal M, Løland BF, et al · · 2025 · PMID 39763277 · DOI 10.1111/jhn.70000

Verify or expand the search:

Other recruiting trials for Cardiovascular Risk Factor

Currently open trials in the same condition.

NCT07268781 — Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients · NA · active not recruiting
NCT06225544 — Lumasiran in Hyperoxalaemic Patients on Haemodialysis · Phase 2 · recruiting
NCT06372054 — TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models · recruiting
NCT05887622 — The Potassium Supplementation Study · NA · recruiting
NCT04962061 — A Combined Multidomain Intervention to Prevent Cognitive Decline Associated With Cardiovascular Risk Factors. · NA · recruiting

Other University of Oslo trials

Trials by the same sponsor.

NCT07346911 — Digital Interventions for Relapse Prevention in Adolescence · NA · not yet recruiting
NCT07499219 — Preliminary Testing and Development of a Short Digital Intervention for Patients on Waiting Lists for Psychological Trea · NA · not yet recruiting
NCT07408687 — Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once - V · NA · not yet recruiting
NCT07287072 — Pain Reprocessing Therapy for Chronic Primary Pain · NA · not yet recruiting
NCT07428694 — From Bench to Bedside: A Machine Learning Tool for the Detection of Inspiratory Leak · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03580057 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oslo
Last refreshed: 21 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03580057.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing